FEMY · FEMASYS INC

Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation. It also provides FemBloc, a non-surgical female permanent birth control solution. The company offers its products to gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

3950 Johns Creek Court, Suwanee, GA, 30024, United States
Medical Instruments & Supplies
Healthcare

Market Cap

10.72M

52 Wk Range

$1.25 - $20.80

Previous Close

$1.28

Open

$1.29

Volume

110,544

Day Range

$1.07 - $1.30

Enterprise Value

-6.863M

Cash

23.91M

Avg Qtr Burn

-4.818M

Insider Ownership

4.02%

Institutional Own.

55.01%

Qtr Updated

Sep 30th 2026